Facility Fit without the Bottlenecks
AES performs facility-fit evaluations to help you understand how your bioprocess aligns with our in-house capabilities and whether any adjustments are needed.
Rapid, Reliable Tech Transfer for Microbial Biologics
AES Biologics accelerates tech transfer for programs at any stage, helping innovators move confidently toward development, scale-up, and IND readiness with speed, clarity, and scientific rigor
Why Tech Transfer Matters More Than
Early-stage and established biologics companies face the same core pressures:
- You need to reduce development risk
- You need predictable timelines driven by right-first-time (RTF) execution
- You need a partner to translate complex science into manufacturable, scalable processes.
Delays in tech transfer are a leading cause of budget overruns and stalled IND submissions. AES Biologics applies an RTF mindset to tech transfer—compressing timelines, minimizing rework, and maintaining transparency so programs move forward with confidence, no matter the starting point.
Our Philosophy: Tech Transfer as A Strategy
At AES Biologics, tech transfer is more than a data exchange. It’s a structured, science-driven process that ensures your molecule is ready for development, scale-up, and GMP alignment.
Our team applies engineering discipline, analytical insight, and regulatory alignment from day one, no after if your program begins with a genetic sequence, an existing strain, or a fully developed technical package. This results in a smoother transition into development and provides a stronger foundation for future manufacturing.
What Makes AES Tech Transfer Different
The AES Biologics facility is sized and configured to support early-stage and first-in-human programs while maintaining the rigor required for clinical manufacturing.
Capital-Efficient Development
Our engineering-first approach improves yield, stability, and process robustness while reducing avoidable costs associated with rework or poor process design.
Engineering + Automation from the Beginning
We apply automation, digital systems, and process control early in development to improve consistency and accelerate future scale-up. Creating a more predictable, data-driven path toward GMP production
Regulatory & Documentation Alignment
We generate development reports aligned with ICH QbD expectations so you can incorporate them into regulatory filings. Minimizing back-and-forth during IND preparation and streamlining clinical readiness
What We Evaluate During Tech Transfer
We focus on the factors that determine whether a program can move forward efficiently and successfully:
- Strain or cell line suitability
- Process and scale fit
- Analytical completeness
- Engineering and automation requirements
- Documentation Quality
- Risk factors
- Opportunities to improve stability, yield, or reproducibility
This evaluation is high-level, collaborative, and designed to support a seamless transition into development work.
What our Tech Transfer Process Looks Like
Step 1: Scientific & Process Assessment
We review available data to understand the molecule, its behaviour, and the path to manufacturability
Step 2: Engineering Digital Mapping
Our team identifies automation needs, process controls, scale considerations, and data requirements to enable development
Step 3. Development Execution
Depending on program maturity, this could include strain development, optimization, or pilot-scale work, with an emphasis on speed and consistency.
Step 4: IND-Ready Documentation
We deliver well-organized, regulatory-aligned documentation to support IND submissions and future manufacturing stages
Who We Support
AES Biologics partners with companies across a broad spectrum of development maturity. We work with early research teams preparing to translate their first molecule into development, to established biotech organizations advancing new programs or transitioning existing ones.
Our Ideal Partners value
- Clear communication
- Predictable timelines
- Strong Scientific and engineering collaboration
- High-quality development supporting regulatory success
If your molecule requires thoughtful, efficient, and technically rigorous transfer into a capable development environment, we can help.
What success looks like
Faster movement from concept to development
Few delays and schedule surprises
Strong scientific understanding of the molecule
Clear, IND-ready documentation
A reliable path toward scale-up and GMP readiness
Why AES Biologics?
Whether you’re preparing your first development programs or advancing a mature process, we provide a tech transfer approach that positions you for success today and tomorrow.
Fast, reliable, and transparent
Built on engineering & scientific depth
Designed for capital efficiency and reduced risk
Supported by automation, data, and quality systems
Ready to scale as your program grows
Start Your Tech Transfer with Confidence
Whether you’re preparing for development, scale-up, or IND submission, AES Biologics provides a disciplined, right-first-time approach that keeps programs moving forward. Let’s discuss your timeline, your data, and your next milestone.